Lipocine Inc.
LPCN
$3.56
$0.257.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 100.05% | 75.12% | 29.60% | 19.50% | -51.99% |
| Total Depreciation and Amortization | 43.71% | 44.40% | 80.66% | 156.35% | 201.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -112.51% | -121.12% | 438.07% | 336.98% | 927.67% |
| Change in Net Operating Assets | -148.03% | -118.97% | 96.24% | 344.70% | 317.36% |
| Cash from Operations | 89.71% | 57.67% | 61.56% | 53.96% | 0.86% |
| Capital Expenditure | -582.58% | 11.32% | 90.86% | 91.71% | 90.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -80.64% | -65.52% | -62.65% | -72.76% | -9.22% |
| Cash from Investing | -81.31% | -65.94% | -62.42% | -72.59% | -8.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -48.94% | -48.94% | 11,583.02% | 7,490.74% | 93.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 150.00% | 92.42% | 100.00% |
| Cash from Financing | -48.27% | -49.50% | 3,755.56% | 126.73% | 119.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.65% | -119.68% | 1,508.06% | -75.08% | 719.85% |